Abstract
A haematological condition known as Immune-Mediated Haemolytic Anaemia (IMHA) affects dogs and is caused by antibodies directly destroying red blood cells in the bloodstream. It can be primary (idiopathic) or secondary (caused by neoplastic or infectious illnesses). An attack on circulating red blood cells by the immune system is the hallmark of IMHA, a potentially fatal autoimmune disease. Though the disease occurs naturally in both humans and dogs, it is significantly more prevalent in dogs. The aim of this review was to methodically assess the available data on the disease's clinico-pathology, its therapy and utilize the results to derive recommendations that may be implemented in broader veterinary medicine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
